S&P Futures
3,932.25 +32.75 (+0.84%) Dow Futures
31,507.00 +294.00 (+0.94%) Nasdaq Futures
11,900.75 +60.00 (+0.51%) Russell 2000 Futures
1,789.60 +17.40 (+0.98%) Crude Oil
111.36 +1.08 (+0.98%) Gold
1,858.40 +16.30 (+0.88%)
VictoryShares US Multi-Factor Minimum Volatility ETF (VSMV)
| Previous Close | 37.87 |
| Open | 37.44 |
| Bid | 33.67 x 900 |
| Ask | 0.00 x 1000 |
| Day's Range | 37.02 - 38.21 |
| 52 Week Range | 37.02 - 42.61 |
| Volume | |
| Avg. Volume | 8,349 |
| Net Assets | 147.9M |
| NAV | 37.83 |
| PE Ratio (TTM) | N/A |
| Yield | 1.45% |
| YTD Daily Total Return | -9.60% |
| Beta (5Y Monthly) | 0.80 |
| Expense Ratio (net) | 0.35% |
| Inception Date | 2017-06-21 |
- Simply Wall St.
At US$11.34, Is It Time To Put 3D Systems Corporation (NYSE:DDD) On Your Watch List?
While 3D Systems Corporation ( NYSE:DDD ) might not be the most widely known stock at the moment, it received a lot of...
- GlobeNewswire
3D Systems Announces CFO Transition and Reiterates 2022 Guidance
Veteran CFO Wayne Pensky to serve as Interim Chief Financial OfficerCompany reiterates 2022 full-year guidance ROCK HILL, S.C., April 25, 2022 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced that Jagtar Narula is stepping down as the company’s Chief Financial Officer, effective May 20, 2022, to accept a new career opportunity. Wayne Pensky, former chief financial officer of Hexcel Corporation (NYSE:HXL), has been appointed interim CFO, effective May 21. The company has initiated an exe
- GlobeNewswire
3D Systems Announces VSP® Bolus to Optimize Radiotherapy Targeting, Improve Patient Experience
3d-systems-vsp-blous-face-demo-render-300ppi.png 3D Systems’ VSP Bolus solution delivers high-quality, patient-specific devices that contour to the patient’s anatomy, enabling more efficacious treatment and a more comfortable experience Latest innovation for company’s VSP solutions is the only complete design and production service available for radiation therapy professionals3D printing of the patient-specific shape reduces air gaps and improves efficacy of treatment ROCK HILL, S.C., April 21,
